Inhibiting GLS1 enhances the efficacy of ferroptosis inhibitors in suppressing tumour growth, and simultaneously targeting GPX4 and GPX1 offers a powerful anti‐cancer approach. This evidence concerns the gene GPX1 and neoplasm.